Key Insights

Highlights

Success Rate

73% trial completion

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

8.8%

3 terminated out of 34 trials

Success Rate

72.7%

-13.8% vs benchmark

Late-Stage Pipeline

15%

5 trials in Phase 3/4

Results Transparency

75%

6 of 8 completed with results

Key Signals

6 with results73% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (10)
Early P 1 (1)
P 1 (3)
P 2 (11)
P 3 (5)

Trial Status

Unknown10
Completed8
Recruiting7
Active Not Recruiting5
Terminated3
Not Yet Recruiting1

Trial Success Rate

72.7%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT02465060Phase 2Active Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

NCT07283939Not ApplicableRecruiting

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

NCT04713618Active Not Recruiting

Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy

NCT01696981Not ApplicableActive Not Recruiting

Screening for Colorectal Cancer in Older Patients (PLCO Screening Trial)

NCT06965166RecruitingPrimary

Contrast-Enhanced Photon-Counting Detector CT (PCD-CT) for the Local Staging of Rectal Cancer

NCT07407647Phase 2Recruiting

Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer

NCT06424522Not ApplicableRecruiting

A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients

NCT07405476Phase 2Recruiting

Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment

NCT04749108Phase 2Recruiting

Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma

NCT02432963Phase 1Active Not Recruiting

Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy

NCT07363863Not Yet RecruitingPrimary

Pattern of Treatment and Outcomes of Locally Advanced Rectal Carcinoma

NCT04505553Phase 2Completed

Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer

NCT06645808Early Phase 1Recruiting

PET-imaging of Two Vartumabs in Patients With Solid Tumors

NCT02000050Phase 2CompletedPrimary

Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE)

NCT06662643Not ApplicableActive Not Recruiting

A Clinical Trial Comparing Staged Turnbull-Cutait Pull-through Anastomosis With Direct Anastomosis Plus Prophylactic Ileostomy in the Treatment of Low Rectal Cancer After Internal Sphincter Resection

NCT04205955Phase 2CompletedPrimary

Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors

NCT02551237Phase 3CompletedPrimary

Neoadjuvant Treatment for Advanced Rectal Carcinoma

NCT04066894Phase 2Terminated

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

NCT05685680Not ApplicableUnknownPrimary

Outcome of Laparoscopic Total Mesorectal Excision Versus Open Technique in Management of Rectal Carcimoma

NCT02817126Not ApplicableUnknownPrimary

Robot-assisted Versus Laparoscopic Surgery for Mid/Low Rectal Cancer

Scroll to load more

Research Network

Activity Timeline